Glooko Rolls Out Insulin Pump Settings EHR Integration

Glooko has launched its Insulin Pump Settings Electronic Health Record (EHR) Integration, a new and first-of-its-kind function in its latest software release that visualizes insulin pump configuration data into the clinical workflow.

Historically, information like basal schedules, insulin-to-carbohydrate ratios, insulin sensitivity factors, blood glucose target ranges, closed-loop status, and active insulin time has lived outside the EHR isolated in external software, PDFs or screenshots, requiring clinicians and staff to toggle between systems, manually transcribe data or copy and paste pump settings into visit notes.

Glooko’s Pump Settings EHR Integration aims to replace that fragmented workflow with structured, discrete pump settings data visualized in EHR flowsheets. That data can be pulled automatically into clinical documentation using SmartText-style workflows, depending on EHR configuration.

“Pump settings are the source of truth for how an insulin pump is delivering therapy; however, traditional documentation requires manual transcription of up to 24 different data points into the EHR,” said Mark Clements, MD, Ph.D., chief medical and strategy officer at Glooko. “When clinicians can see settings such as basal rates, insulin-to-carbohydrate ratios, correction factors, active insulin time and closed-loop status in the same workflow as glucose data and the patient note, the visit becomes less about finding and transcribing information and more about acting on it. This integration, which is unique to Glooko, gives care teams a more complete view of insulin therapy today and creates the structured data foundation for more advanced clinical decision support in the future—where discrete pump settings, glucose trends and other diabetes data can work together to surface more timely, actionable insights. By reducing reliance on incomplete, stale or manually transcribed information, Glooko is helping clinics make therapy adjustments with greater context, consistency and confidence.”

The company adds a specialized, device-agnostic diabetes data layer to help normalize pump data across manufacturers and deliver it into the EHR as usable clinical context. The result is another management layer for clinics, specifically device data, EHR documentation, and diabetes care decisions.

Glooko supports centralization of diabetes data from over 200 diabetes and health monitoring devices. It integrated with leading EHR systems to reduce platform switching and streamline care workflows.

“Health systems are asking for diabetes data to be more connected, usable and embedded in the way care is actually delivered,” said Rich Glenn, president of Connected Care at Glooko. “By bringing device-agnostic pump settings into EHR flowsheets, Glooko is helping clinics move beyond fragmented portals and manual documentation toward a more connected care experience for providers and people with diabetes.”

Last month, the company earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its EndoTool IV Cloud, which is marketed as the first FDA-cleared, cloud-based, patient-specific insulin dosing platform.